Project Grant HT94252411043
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$786K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
The University of Wisconsin System has been awarded a $516,366 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from September 1, 2024 to August 31, 2027, will fund research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. This research initiative aims to transform healthcare for military service members and the broader...
This federal Project Grant award for $465,935.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research conducted by the University of Wisconsin - Madison to combine PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical...
The University of Wisconsin-Madison will receive $1.17 million over four years through a Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research to interrogate the intersection of prostate-specific membrane antigen and PI3K pathway signaling as a novel treatment approach for treatment-resistant prostate cancer. The University will investigate medical solutions for prostate cancer with the goals of transforming patient...
This federal Project Grant award of $1,251,230.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a breast cancer research project with the University of Wisconsin System. The award will fund a clinical trial focused on breakthrough breast cancer treatments, with a performance period from June 2025 to June 2029. The University of Wisconsin System, a leading public research institution, will serve as the primary awardee and perform the...
The University of Wisconsin-Madison will receive $1,377,598 under a three-year Project Grant from the Defense Health Agency to investigate medical solutions for targeting dysregulated histone-modifying enzymes driving prostate cancer cell survival after androgen deprivation therapy. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield...
The University of Wisconsin System was awarded a $1,074,650 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 1, 2025 to August 31, 2029, will fund research to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by addressing...
The Department of the Army Medical Command awarded a $537,120 Project Grant to the University of Wisconsin-Madison under the Military Medical Research and Development program. The grant will support targeted combination therapy research in a novel in vivo model of fibrolamellar carcinoma from August 1, 2022 to July 31, 2024. The Military Medical Research and Development program aims to advance biomedical research that transforms military and public health care. This award will fund the...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
This federal Project Grant award of $1,235,845.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research project led by the University of Illinois in Chicago. The project aims to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award period runs from August 15, 2025 to August 14, 2028. The Military Medical Research and Development program funds...
The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from April 15, 2025 to April 14, 2029, will support research to develop population modeling techniques aimed at optimizing equitable ovarian cancer outcomes. This work aligns with the program's focus on transforming healthcare for military service members, veterans, and the broader public through...